🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sangeeta Goswami

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0001-9201-4503
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy.

67 citations

Sangeeta Goswami, Peter F. Thall, Xuemei Wang, Ying Yuan, Eric Jonasch +21 more

18 citations

Sreyashi Basu, Gerard Baquer, Ryuhjin Ahn, Jennifer Gantchev, Sonali Jindal +71 more

14 citations

Jianjun Gao, Sreyashi Basu, Daniel D. Shapiro, José A. Karam, Rebecca S. Tidwell +22 more

6 citations

Sreyashi Basu, Gerard Baquer, Ryuhjin Ahn, Jennifer Gantchev, Sonali Jindal +44 more

N/A
0DataRank · unranked
4 citations

Saifudeen Abdelrahim, Majd Al Shaarani, Huifang Lu, Raisa Ahmad, Sangeeta Goswami +2 more

12 citations

Omar Alhalabi, Sangeeta Goswami, Padmanee Sharma, Kristen E. Pauken

19 citations

Shelley M. Herbrich, Sangeeta Goswami, Baoxiang Guan, Yulong Chen, Marc Macaluso +12 more